Adagio Therapeutics Inc (ADGI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 153,774 | 145,274 | 96,947 | 107,743 | 59,033 |
| Cost of Goods | 114,904 | 90,430 | 63,253 | 79,975 | 50,864 |
| Gross Profit | 38,870 | 54,844 | 33,694 | 27,768 | 8,169 |
| Operating Expenses | 29,885 | 19,556 | 13,866 | 13,376 | 13,306 |
| Operating Income | 9,889 | 35,718 | 20,081 | 15,367 | -4,274 |
| Interest Expense | 2,491 | 2,087 | 1,666 | 1,524 | 1,102 |
| Other Income | -24 | 1,806 | 329 | 1,144 | 1,618 |
| Pre-tax Income | 7,374 | 35,437 | 18,744 | 14,987 | -3,758 |
| Income Tax | 4,656 | 14,543 | 8,377 | 6,281 | -476 |
| Net Income Continuous | 2,718 | 20,894 | 10,367 | 8,705 | -3,282 |
| Net Income Discontinuous | N/A | N/A | N/A | 517 | -746 |
| Net Income | $2,718 | $20,894 | $10,367 | $9,222 | $-4,028 |
| EPS Basic Total Ops | 0.49 | 3.94 | 2.11 | 1.90 | -0.84 |
| EPS Basic Continuous Ops | 0.49 | 3.94 | 2.11 | 1.79 | -0.68 |
| EPS Basic Discontinuous Ops | N/A | N/A | N/A | 0.11 | -0.16 |
| EPS Diluted Total Ops | 0.48 | 3.73 | 2.10 | 1.90 | -0.84 |
| EPS Diluted Continuous Ops | 0.48 | 3.69 | 2.10 | 1.79 | -0.68 |
| EPS Diluted Discontinuous Ops | N/A | N/A | N/A | 0.11 | -0.16 |
| EBITDA(a) | $14,168 | $39,040 | $22,306 | $17,562 | $-2,137 |